Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while ...
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback